We are live on ! Find out more
TC

Tejara Capital Portfolio holdings

AUM $303M
1-Year Est. Return 5.43%
This Fund
S&P 500
This Quarter Est. Return
-4.23%
1 Year Est. Return
+5.43%
3 Year Est. Return
+13.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$275M
AUM Growth
+$2.93M
Cap. Flow
+$14.7M
Cap. Flow %
5.35%
Top 10 Hldgs %
43.8%
Holding
92
New
17
Increased
31
Reduced
13
Closed
24

Top Buys

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$10.5M
2
CRC icon
California Resources
CRC
+$6.71M
3
DFS
Discover Financial Services
DFS
+$6.28M
4
MD icon
Pediatrix Medical
MD
+$4.99M
5
RIG icon
Transocean
RIG
+$4.52M

Top Sells

Rank Stock Value
1
STNG icon
Scorpio Tankers
STNG
+$23.2M
2
GLNG icon
Golar LNG
GLNG
+$12M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.57M
4
ROIV icon
Roivant Sciences
ROIV
+$4.56M
5
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$3.75M

Sector Composition

Rank Sector Weight
1 Healthcare 40.95%
2 Energy 28.93%
3 Industrials 6.09%
4 Communication Services 5.72%
5 Financials 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SSYS icon
26
Stratasys
SSYS
$707M
$3.82M 1.39%
455,596
+158,963
+54% +$1.51M
SLB icon
27
SLB Ltd
SLB
$70.3B
$3.7M 1.34%
78,397
+58,397
+292% +$2.82M
FET icon
28
Forum Energy Technologies
FET
$593M
$3.69M 1.34%
218,919
+5,485
+3% +$101K
CRDL
29
Cardiol Therapeutics
CRDL
$139M
$3.48M 1.26%
1,722,243
+77,833
+5% +$165K
ADPT icon
30
Adaptive Biotechnologies
ADPT
$3.67B
$3.29M 1.2%
909,061
+640,047
+238% +$2.03M
XPER icon
31
Xperi
XPER
$352M
$3.09M 1.12%
375,908
+172,269
+85% +$1.63M
SCPH
32
DELISTED
scPharmaceuticals
SCPH
$3.07M 1.11%
704,742
+6,556
+0.9% +$28.8K
EDR
33
DELISTED
Endeavor Group Holdings, Inc.
EDR
$2.7M 0.98%
+100,000
New +$2.66M
RNW icon
34
ReNew
RNW
$2.29B
$2.69M 0.98%
430,944
+159,700
+59% +$959K
DNN icon
35
Denison Mines
DNN
$2.55B
$2.63M 0.96%
1,324,058
– –
ZYME icon
36
Zymeworks
ZYME
$1.78B
$2.3M 0.84%
270,212
+60,000
+29% +$534K
CSTM icon
37
Constellium
CSTM
$3.83B
$1.97M 0.72%
104,500
+74,500
+248% +$1.55M
SDGR icon
38
Schrodinger
SDGR
$1.14B
$1.96M 0.71%
+101,240
New +$2.33M
BIDU icon
39
Baidu
BIDU
$36.5B
$1.87M 0.68%
21,600
+12,000
+125% +$1.21M
CHRS icon
40
Coherus Oncology
CHRS
$216M
$1.78M 0.65%
1,030,386
-25,000
-2% -$50.3K
BP icon
41
BP
BP
$108B
$1.76M 0.64%
+48,838
New +$1.83M
HAL icon
42
Halliburton
HAL
$29.4B
$1.69M 0.61%
+50,000
New +$1.85M
QDEL icon
43
QuidelOrtho
QDEL
$1.19B
$1.47M 0.54%
44,400
-25,600
-37% -$1.05M
IMVT icon
44
Immunovant
IMVT
$8.27B
$1.46M 0.53%
+55,210
New +$1.57M
FIP icon
45
FTAI Infrastructure
FIP
$492M
$1.45M 0.53%
167,604
+13,619
+9% +$104K
TSAT icon
46
Telesat
TSAT
$554M
$1.44M 0.52%
158,235
-10,000
-6% -$81.3K
MATV icon
47
Mativ Holdings
MATV
$442M
$1.42M 0.52%
83,853
-40,485
-33% -$722K
OSG
48
Octave Specialty Group
OSG
$275M
$1.28M 0.47%
+100,000
New +$1.53M
TRVI icon
49
Trevi Therapeutics
TRVI
$2.71B
$1.21M 0.44%
405,988
+368,507
+983% +$1.02M
OPK icon
50
Opko Health
OPK
$899M
$1.13M 0.41%
+905,372
New +$1.17M
1
2
3 4

Similar funds

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
ECAM
East Coast Asset Management Essex, Massachusetts $303M AUM 35.55% 1-Year Est. Return
BPH
Boundless Plain Holdings Hong Kong $304M AUM
DFG
Demars Financial Group Spokane Valley, Washington $304M AUM 17.94% 1-Year Est. Return
BCC
Bain Capital Credit Boston, Massachusetts $303M AUM 15.47% 1-Year Est. Return
BKA
Brick & Kyle Associates Newtown, Pennsylvania $303M AUM 26.39% 1-Year Est. Return
SF
Slagle Financial Edwardsville, Illinois $303M AUM 23.03% 1-Year Est. Return
AFO
Arrowroot Family Office Marina Del Rey, California $302M AUM 14.21% 1-Year Est. Return

Tejara Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Tejara Capital held 92 positions worth $275M, up 1.1% from $272M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Tejara Capital deployed $14.7M of net new capital in Q2 2024, opening 17 new positions and adding to 31 existing holdings. Its largest new stake was Global Payments: 95,000 shares worth $9.19M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 38% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $5.57M trimmed.

  • Tejara Capital's largest Q2 2024 buy was Global Payments: 95,000 shares worth $9.19M.
  • Tejara Capital added most to Transocean in Q2 2024, an estimated $4.52M increase.
  • Tejara Capital's biggest Q2 2024 reduction was Teva Pharmaceuticals, cutting an estimated $5.57M.
  • Tejara Capital fully exited Scorpio Tankers in Q2 2024, selling an estimated $23.2M.
  • Tejara Capital's ten largest holdings make up 44% of its $275M portfolio in Q2 2024.
  • Tejara Capital opened 17 new positions and closed 24 in Q2 2024.
  • Tejara Capital's portfolio value rose 1.1% quarter-over-quarter to $275M.

Based on Tejara Capital's 13F filing for Q2 2024, filed 14 Aug 2024.